Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
AI is an increasingly useful tool in pathology—but its full value can only be realized in collaboration with human experts.
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.